Your browser doesn't support javascript.
loading
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients.
Yan, Chi; Chen, Sheau-Chiann; Ayers, Gregory D; Nebhan, Caroline A; Roland, Joseph T; Weiss, Vivian L; Johnson, Douglas B; Richmond, Ann.
Affiliation
  • Yan C; Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN, USA.
  • Chen SC; Vanderbilt University School of Medicine, Department of Pharmacology, Nashville, TN, USA.
  • Ayers GD; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Nebhan CA; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Roland JT; Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN, USA.
  • Weiss VL; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Johnson DB; Departments of Surgery and Pediatrics and the Epithelial Biology Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Richmond A; Vanderbilt University School of Medicine, Department of Pharmacology, Nashville, TN, USA.
NPJ Precis Oncol ; 6(1): 6, 2022 Jan 20.
Article in En | MEDLINE | ID: mdl-35058553
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido